Boehringer Ingelheim – Faulty Drugs

Saturday, November 23, 2024

Latest:

Pfizer withdraws all lots of OXBRYTA (voxelotor)
Wegovy lawsuit
Tepezza Lawsuit
The key factors that could contribute to the emergence of a new pandemic virus
FDA recalls Quinapril linked to Cancer

Faulty Drugs

Faulty Pharmaceutical Drugs Resources

November 18, 2008

Tiotropium risk of stroke and reports of cardiovascular adverse outcomes

Tiotropium (marketed as Spiriva HandiHaler) FDA informed healthcare professionals that FDA has reviewed preliminary data from UPLIFT (Understanding the Potential